News.
From our community.

Company post · English edition

Preparing the sample

Correct sample preparation makes the difference.

In the microbiology laboratory, efficiency concerns every preceding step, as well as the final result.

SpinAX combined with Axonlab’s ProbeAX Evolution offers a specialised solution for homogenising tissue samples, designed to simplify processing and support a more organised laboratory workflow.

What does this mean in practice?

• Homogenisation inside the specially designed sample tube.

• Single-use consumables, without having to clean reusable homogenisation vessels.

• A process designed for fast, practical sample processing.

Laboratory innovation does not need to be complicated. It needs to provide meaningful value in everyday practice.

SpinAX + ProbeAX Evolution | Axonlab

For further information, contact our team.

Company post · English edition

Introducing ProbeAX Evolution

ProbeAX Evolution: reliability in homogenising primary biological material

Correct sample preparation is a critical step for the accuracy of laboratory analysis.

ProbeAX Evolution is designed for effective, reproducible homogenisation of primary biological material, supporting the needs of demanding modern laboratories.

The company’s presentation highlights:

• A homogeneous result with minimal sample loss.

• Consistent performance and control during processing.

• Suitability for different types of biological material.

• An ergonomic design for everyday laboratory use.

The original post included a video reference.

Company post · English edition

The company’s SpinAX presentation

The company presented SpinAX by Axonlab as a compact, quiet, reliable instrument for homogenising tissue samples and biopsies in microbiology, exclusively using ProbeAX Evolution tubes. The post describes improved microbial recovery, reduced contamination risk and an anti-blocking safety function.

Main characteristics and benefits as stated in the company’s post:

Homogenisation: designed to process tissue and bone samples for microbiological and biomolecular analysis.

Performance: described as supporting microbial recovery and reducing contamination risk to facilitate diagnosis.

Design: compact, robust construction, with a stated noise level below 56 dB.

Safety: an anti-blocking function.

Compatibility: exclusive use with ProbeAX Evolution tubes, such as the 40 ml ProbeAX EVO tube containing 5 ml NaCl.

The company presents the system for laboratories seeking a fast, standardised approach to sample preparation.

Company post · English edition

Sponsorship participation

The future is not something we wait for. It is something we shape together.

Medical Trade International is proud to be a sponsor of the 6th Thessaloniki Metropolitan Summit, a leading platform bringing together dialogue, innovation, technology, growth and collaboration across South-East Europe.

At Medical Trade, we believe that progress in Healthcare requires vision, technology and people willing to look beyond today.

With a strong presence in Thessaloniki and a clear commitment to innovation in Healthcare, we continue to invest in partnerships that create value and help shape the future.

Medical Trade International

Innovation. Healthcare. Future.

Company post · English edition

Day one and gala dinner

A memorable first day at the 6th Thessaloniki Metropolitan Summit & Gala Dinner.

An inspiring evening bringing together distinguished leaders, decision-makers and professionals from Greece and beyond, in the heart of Thessaloniki.

Beyond the impressive discussions and insights, what makes events like this truly valuable is the opportunity to connect, exchange ideas and build meaningful relationships with people who share a vision for the future.

It was a great honor to be part of this important gathering and to experience firsthand the energy, dialogue and spirit of collaboration that define the Thessaloniki Metropolitan Summit.

A remarkable first day — and an even more promising journey ahead.

Company post · English edition

Day two and future meetings

6th Thessaloniki Metropolitan Summit | Day 2

The second day of the 6th Thessaloniki Metropolitan Summit brought together leading voices from the business, political and economic community to discuss the challenges and opportunities shaping the future of Greece and Southeast Europe.

Key topics included connectivity, infrastructure, energy, technology, investment and regional development, highlighting the strategic role of Thessaloniki and Northern Greece as an important gateway between Europe and the wider region.

For Medical Trade, participation in high-level platforms such as the Thessaloniki Metropolitan Summit is an opportunity to remain closely connected with the developments shaping our business environment, exchange perspectives and strengthen relationships with partners and stakeholders.

We believe that sustainable growth is built through collaboration, innovation and long-term partnerships.

We are proud to contribute to this dialogue and to continue building meaningful connections across the healthcare and business community.

The conversation continues.

🇨🇾 Our next meeting point: Cyprus | November 9–10

We look forward to welcoming our partners, colleagues and new connections in Cyprus as we continue exploring new opportunities for cooperation and growth.

Medical Trade | Building partnerships. Creating opportunities. Supporting progress in healthcare.

Company post · English edition

Discussing healthcare innovation

From the stage to a tête-à-tête conversation about the future of healthcare.

Following the speech of the Minister of Health, Mr. Adonis Georgiadis, at the Economist: 6th Thessaloniki Metropolitan Summit, CEO Konstantinos Karagiannis had the opportunity to have a personal and constructive discussion with him about the current developments and the future of healthcare in Greece.

The conversation focused on the importance of innovation, modern healthcare processes and the adoption of advanced medical technologies that can contribute to more efficient, accurate and sustainable healthcare services.

On behalf of Medical Trade, he shared our commitment to supporting this direction through the introduction and development of innovative solutions and medical technologies — including Probac Evolution — with the aim of contributing to the continuous improvement of diagnostic processes and clinical practice.

Innovation is not simply about bringing a new technology to the market.

It is about creating real value for healthcare professionals, improving processes and ultimately contributing to better outcomes for patients.

The Minister’s statement was that "Medical Trade International is contributing with success to the evolution of healthcare through innovation and collaboration".

The future of healthcare will be built through dialogue, partnerships and the courage to innovate.

Company post · English edition

Participation as Contributor

Innovation in healthcare is more than our business—it is our commitment.

At Medical Trade International – Greece & Cyprus, we are dedicated to bringing innovative Swiss In Vitro Diagnostics (IVD) solutions to Greece and Cyprus, supporting healthcare professionals and institutions with advanced technologies that contribute to better patient care and improved clinical outcomes.

Our participation as a Contributor at the 30th Annual Government Roundtable by Economist Impact reflects our ongoing commitment to actively engaging in Greece's leading healthcare and business initiatives. We firmly believe that sustainable progress is achieved through innovation, collaboration, and the exchange of ideas that shape the future of healthcare.

Driven by excellence, reliability, and a forward-looking vision, we continue to invest in cutting-edge Swiss technologies and innovative solutions, contributing to the advancement of the healthcare sector while strengthening our presence within the country's medical and business community.

Together, we are helping build a healthier, more innovative future.

Company post · English edition

Day one

Day 1 at the 30th Annual Government Roundtable by The Economist | Grand Resort Lagonissi

An inspiring first day filled with insightful discussions, meaningful networking, and valuable exchanges with government officials, business leaders, academics, and industry experts from Greece and around the world.

As global challenges continue to reshape our future, events like this provide a unique platform to discuss the intersection of geopolitics, economic growth, innovation, and technology.

We are proud that Medical Trade International is part of this prestigious event, reaffirming our commitment to innovation, strategic partnerships, and advancing healthcare through cutting-edge in vitro diagnostic solutions.

Looking forward to the next days of the conference, with more inspiring conversations, new connections, and opportunities to contribute to the future of healthcare.

Company post · English edition

Day two

Day 2 at the 30th Annual Government Roundtable by The Economist | Grand Resort Lagonissi

The second day of the conference concluded in the most distinguished way, with the official gala dinner and the presence of the Prime Minister of Greece.

The discussions, exchange of ideas, and networking opportunities throughout the conference once again highlighted the importance of collaboration, innovation, and leadership in shaping the future of healthcare and the economy.

As a company, we are especially grateful to our esteemed guests who honored us with their presence. Your participation, trust, and engaging conversations made this event even more meaningful and reaffirm the value of strong partnerships built on shared vision and mutual respect.

Thank you for being part of this remarkable experience. We look forward to continuing our journey together, driving innovation and creating value for the healthcare community.

Company post · English edition

Day three

Day 3 | Economist Government Roundtable 2026

The third and final day of the Economist Government Roundtable 2026 marked the conclusion of three inspiring days filled with insightful discussions, meaningful dialogue, and valuable networking.

It was a privilege to participate in one of the region's most influential forums, where government leaders, policymakers, business executives, and industry experts came together to exchange ideas and shape perspectives on the future of healthcare, innovation, investment, and economic growth.

As this remarkable event comes to an end, we would like to express our sincere appreciation to The Economist for the excellent organization and to all the distinguished speakers, partners, and participants who contributed to the success of this year's Roundtable.

A special thank you to our valued guests for honoring us with their presence and for the opportunity to share ideas, strengthen relationships, and build new collaborations.

We leave this event with new insights, stronger connections, and an even greater commitment to supporting innovation and excellence in healthcare.

Company post · English edition

The meeting with the Health Minister

It was a great honor and privilege to meet privately with the Minister of Health, Mr. Adonis Georgiadis, and his team during the Economist Government Roundtable.

Our discussion focused on the innovative medical technologies that Medical Trade International is introducing across Greece and Cyprus, as well as the positive impact these solutions have already demonstrated in hospitals through improved diagnostic accuracy, faster clinical decision-making, and enhanced patient care.

We were particularly encouraged by the Minister's genuine interest in our vision and ongoing work. His commitment to innovation and improving healthcare outcomes was evident throughout our conversation. We are especially honored that he expressed his desire for a follow-up meeting to further explore how we can work together to strengthen the medical community by providing healthcare professionals with cutting-edge technologies that deliver higher quality, faster, and more accurate clinical results.

Innovation in healthcare is not only about advancing technology—it is about improving patient outcomes, supporting healthcare professionals, enabling more precise treatments, and ultimately contributing to more efficient use of healthcare resources and reduced hospitalization costs.

At Medical Trade International, we remain committed to bringing world-class innovation to the healthcare systems of Greece and Cyprus and to building strong partnerships that shape the future of patient care.

Company post · English edition

A moment from the meeting

We are honored to share this special moment from the Economist Government Roundtable, featuring the meeting between the Greek Minister of Health, Adonis Georgiadis, and the CEO of Medical Trade International, Konstantinos Karagiannis.

Their discussion focused on the importance of innovation in healthcare, the introduction of advanced medical technologies in Greece and Cyprus, and Medical Trade International's contribution to supporting hospitals and healthcare professionals with cutting-edge solutions.

We sincerely thank the Minister for the constructive dialogue and the opportunity to exchange views on the future of healthcare. At Medical Trade International, we remain committed to investing in innovation, quality, and partnerships that create real value for patients and healthcare systems.

Company post · English edition

The company post

Medical Trade International at the inauguration of AHEPA’s University Ophthalmology Clinic

Medical Trade International was honoured to attend the inauguration of the University Ophthalmology Clinic at AHEPA University General Hospital in Thessaloniki, a project of significance for healthcare services, university education and scientific research in Greece.

The ceremony was attended by Health Minister Adonis Georgiadis, the Governor of the 4th Health Region of Macedonia and Thrace Panagiotis Boyatzidis, AHEPA Governor Panagiotis Panteliadis, the President of the School of Medicine of Aristotle University of Thessaloniki Professor Stefanos Triaridis, and representatives of the academic and medical community. Their presence marked an initiative supporting ophthalmological care in Greece.

Describing itself as a longstanding AHEPA partner, Medical Trade International expressed pride in supporting the modernisation of healthcare structures through medical technologies and solutions for healthcare professionals and patient services.

Our presence reflects our commitment to initiatives supporting innovation, scientific excellence and the development of hospital infrastructure.

We extend our congratulations to AHEPA’s management, the 4th Health Region, the School of Medicine of Aristotle University of Thessaloniki, and the medical, nursing and administrative staff who contributed to this project.

The University Ophthalmology Clinic represents an important step for public healthcare, medical education and services for citizens. Medical Trade International will continue supporting initiatives that strengthen innovation and the development of a modern, effective healthcare system.

Company post · English edition

The symposium announcement

We are pleased to participate in ESGARS 2026, contributing to discussion of one of the major challenges in contemporary public health: antimicrobial resistance (AMR).

During Satellite Symposium 8, Lemonia Skoura, Professor of Microbiology at Aristotle University of Thessaloniki and AHEPA University General Hospital, will present:

“Tissue homogenization as an effective pre-analytical step in clinical microbiology”.

The presentation addresses an approach to optimising pre-analytical processes in clinical microbiology and supporting the reliability of diagnostic results.

Venue: Divani Caravel Hotel, Athens.

Conference: 20–23/05/2026.

Symposium: Saturday 23/05/2026 · 13:30–14:00.

Knowledge exchange and cooperation between the scientific community and healthcare professionals are essential to tackling AMR.

Company post · English edition

The company’s account

Our participation in the 8th EEPDE Congress (Hellenic Society for Paraclinical Diagnostic Testing) provided an excellent opportunity for meaningful dialogue with the medical community, particularly cardiologists.

Presentations and discussions highlighted the importance of correct pre-analytical procedures when handling samples for point-of-care systems. Sample quality and correct preparation are key factors in reliable results.

In an emergency department, time is critical. Prompt, accurate diagnosis of an infection can influence a patient’s course. Correct use of point-of-care technologies can support:

• Timely infection detection.

• Better-informed clinical decisions.

• Rational selection of antibiotic treatment.

Improving knowledge of pre-analytical stages is an investment in quality of care and patient safety, rather than simply a technical detail.

We continue supporting education and innovation, with the aim of providing reliable diagnostic solutions where they matter: alongside the patient.

Company post · English edition

The invitation

We are pleased to announce our participation in the Hellenic Society for Microbiology Days 2026, organised by the Hellenic Society for Microbiology on 26–28/02/2026 at Crowne Plaza Athens City Centre.

The central theme is:

“The modern clinical laboratory: developments and prospects in medical biopathology”.

The congress will address new technologies, innovative practices and strategies shaping the future of clinical laboratories.

Clinical workshops and the scientific programme offer opportunities to learn, exchange experiences and discuss challenges and opportunities in medical biopathology.

We look forward to meeting partners, scientists and healthcare professionals, exchanging perspectives and discussing solutions supporting quality, reliability and efficiency in modern laboratories.

Meet us in Athens, 26–28/02/2026.

Company post · English edition

After the congress

We were pleased and proud to participate as sponsors in the Hellenic Society for Microbiology Days at the Crowne Plaza Athens City Centre.

The congress brought together microbiologists, medical biopathologists and healthcare professionals from across Greece. Its scientific programme and strong participation highlighted the rapid development of laboratory medicine and the need for practical solutions.

Our presentation addressed:

“The necessity of homogenisation in microbiological and molecular testing”.

We discussed in depth:

• The critical role of correct pre-analytical procedures.

• The effect of homogenisation on reliability and reproducibility.

• Its contribution to molecular testing accuracy.

• Reducing errors and repeat testing that consume time and resources.

The scientific staff’s response was particularly encouraging. Questions, constructive dialogue and interest following the presentation reflected the importance of homogenisation for quality in modern microbiological and molecular diagnosis.

Many doctors approached us for further discussion, exchange of views and exploration of cooperation. These are the moments that give scientific congress participation its value: knowledge becomes practice and innovation finds an application.

We warmly thank the President of the Hellenic Society for Microbiology, Professor Athanasios Tsakris, for the opportunity to speak at this congress.

Our thanks also go to the organisers for their hospitality and to all healthcare professionals who attended and contributed their scientific perspectives.

We continue our commitment to quality, innovation and meaningful support for the laboratory community.

Company post · English edition

The original announcement

Medical Trade International is pleased to announce its participation as Gold Sponsor in Hospital Hi-Tech 2026, originally announced for Zappeion Hall on 21–22/02/2026.

The scientific round tables include:

Saturday 21 February: Lemonia Skoura, Professor of Biopathology and Microbiology at Aristotle University of Thessaloniki and Director of AHEPA’s Microbiology Department, presenting:

“The importance of the pre-analytical process in microbiological and molecular diagnosis: the role of tissue processing”.

Sunday 22 February: Iordanis Iordanidis, presenting:

“The importance of pre-analysis in microbiological and molecular testing”.

Our participation as Gold Sponsor reflects our commitment to innovation, biotechnology and scientific support for the medical community.

We look forward to meeting you.

Venue update: the company’s subsequent correction moved the event to Royal Olympic Hotel. The original Zappeion location is historical information.

Company post · English edition

The venue correction

Please note that the Hospital Hi-Tech / Innovation–Biotechnology conference will not take place at Zappeion Hall, as originally announced.

The event will be hosted at Royal Olympic Hotel on 21–22/02/2026.

The scientific programme and scheduled lectures will proceed as planned.

We look forward to welcoming you at the new venue for this scientific conference.

Company post · English edition

The account of the event

Royal Olympic Hotel recently hosted a scientific congress dedicated to innovative technologies and contemporary developments in healthcare.

Scientists, healthcare professionals and industry representatives exchanged views, presented research and discussed the prospects shaping patient care.

The presentation of ProbeAX Evolution had a prominent place in the programme. According to the company’s account, it received positive feedback from the scientific community. The system, its ergonomic design and its potential value in daily practice were discussed in a detailed presentation and an interactive session.

A particular honour was the lecture by Professor Skoura, with Professor Pournaras chairing the session. Drawing on their scientific expertise and experience, they discussed medical technology development and appropriate integration into clinical practice. Their presentations combined theoretical background with practical applications, offering knowledge and further questions for the delegates.

The company also reported the presentation of the Hippocratic Award to Professors Skoura and Pournaras in recognition of their longstanding contribution to science and healthcare quality. The award was described as a message supporting excellence, innovation and dedication to people.

The congress demonstrated the continued development of healthcare in Greece through technology, scientific cooperation and recognition of those contributing to progress.

The company concluded that the event’s success and the response to ProbeAX Evolution support a future in which innovation and scientific knowledge remain central.

Company post · English edition

The sponsorship announcement

Medical Trade International is proud to announce its participation as Gold Sponsor in the 40th Postgraduate Seminar, taking place at Macedonia Palace on 6–8 February.

Our active presence at scientific events reflects our strategic commitment to continuing education, quality and support for the medical community.

We invite you to visit our team during the congress, discover our solutions and discuss contemporary needs and innovative approaches.

Company post · English edition

Invitation to the stand

Visit our stand at the 40th Postgraduate Seminar of Medical Biopathology of Northern Greece to discuss contemporary developments in healthcare.

Through meaningful dialogue, exchange of experience and presentation of innovative solutions, we aim to contribute to the continuous development of medical biopathology.

Meet our team, exchange views and explore the future of healthcare together.

Company post · English edition

The account and clinical reference

Medical Trade International participated in the 40th Postgraduate Seminar of Medical Biopathology of Northern Greece, held on 6–8 February.

During a round-table discussion, the importance of homogenisation in microbiological and molecular testing was presented, highlighting its role in the reliability of diagnostic results.

Our company remains a committed supporter of healthcare advancement and scientific progress.

The company’s account highlights an announcement by Lemonia Skoura, Professor of Biopathology and Microbiology at Aristotle University of Thessaloniki and AHEPA’s Microbiology Department: in a request for microbiological testing of pleural fluid, Nocardia and Candida were detected. The post describes this as a finding of clinical significance, illustrating the importance of appropriate, targeted laboratory investigation.

Company post · English edition

The company post

The 20th Panhellenic Congress of EDDYPPY, held in Ioannina, brought together healthcare organisations, scientists and companies contributing to prevention and public health services. The congress highlighted the evolving needs of healthcare and the value of technological development in addressing contemporary challenges.

We warmly thank Giorgos Patoulis, President of EDDYPPY and the Athens Medical Association, for the opportunity to present our innovative solutions.

Medical Trade’s participation reflected its commitment to healthcare progress and scientific activities. Founder Konstantinos Karagiannis discussed the company’s vision and presented ProbeAX Evolution and BACT-R Plus, generating interest and discussion among professionals and scientists.

The company described these products as solutions supporting healthcare and new approaches to individualised medical diagnosis.

For Medical Trade, the congress offered an opportunity to connect scientific knowledge, innovation and practical tools for the medical community. It reaffirmed the company’s ambition to contribute to developments in healthcare through knowledge, safety and technology.